Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 44 Records) |
Query Trace: Colorectal Neoplasms and meta-analysis and EGFR[original query] |
---|
Which is false: oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody. Cancer science 2013 Oct 104 (10): 1330-8. Wen Feng, Tang Ruilei, Sang Yaxiong, Li Meng, Hu Qiancheng, Du Zedong, Zhou Yi, Zhang Pengfei, He Xiaofeng, Li Q |
The prognostic role of BRAF mutation in metastatic colorectal cancer receiving anti-EGFR monoclonal antibodies: a meta-analysis. PloS one 2013 8 (6): e65995. Yuan Zi-Xu, Wang Xiao-Yan, Qin Qi-Yuan, Chen De-Feng, Zhong Qing-Hua, Wang Lei, Wang Jian-Pi |
PCR-based assays versus direct sequencing for evaluating the effect of KRAS status on anti-EGFR treatment response in colorectal cancer patients: a systematic review and meta-analysis. PloS one 2014 9 (9): e107926. Shan Lianfeng, Li Ming, Ma Jianzhong, Zhang Huid |
The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis. OncoTargets and therapy 2014 7 1487-96. Ying Hou-Qun, Wang Feng, He Bang-Shun, Pan Yu-Qin, Gao Tian-Yi, Xu Ye-Qiong, Li Rui, Deng Qi-Wen, Sun Hui-Lin, Wang Shu-K |
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Jan 26 (1): 13-21. Sorich M J, Wiese M D, Rowland A, Kichenadasse G, McKinnon R A, Karapetis C |
Let-7 microRNA-binding-site polymorphism in the 3'UTR of KRAS and colorectal cancer outcome: a systematic review and meta-analysis. Cancer medicine 2014 Oct 3 (5): 1385-95. Langevin Scott M, Christensen Brock |
Anti-epidermal growth factor receptor monoclonal antibody-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of PIK3CA mutations in KRAS wild-type patients. Archives of medical science : AMS 2014 Feb 10 (1): 1-9. Huang Lulu, Liu Zhenfang, Deng Donghong, Tan Aihua, Liao Ming, Mo Zengnan, Yang Xiao |
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis. Acta oncologica (Stockholm, Sweden) 2014 Jul 53 (7): 852-64. Therkildsen Christina, Bergmann Troels K, Henrichsen-Schnack Tine, Ladelund Steen, Nilbert M |
EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment: a meta-analysis. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2014 Feb 26 (1): 59-71. Shen Wei-Dong, Chen Hong-Lin, Liu Peng-F |
BRAF V600E mutation as a predictive factor of anti-EGFR monoclonal antibodies therapeutic effects in metastatic colorectal cancer: a meta-analysis. Chinese medical sciences journal = Chung-kuo i hsüeh k'o hsüeh tsa chih / Chinese Academy of Medical Sciences 2014 Dec 29 (4): 197-203. Wang Qi, Hu Wei-guo, Song Qi-bin, Wei J |
Effect of BRAF V600E mutation on tumor response of anti-EGFR monoclonal antibodies for first-line metastatic colorectal cancer treatment: a meta-analysis of randomized studies. Molecular biology reports 2014 Mar 41 (3): 1291-8. Cui Dandan, Cao Dan, Yang Yu, Qiu Meng, Huang Ying, Yi Che |
FCGR2A, FCGR3A polymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer. Oncotarget 2015 Aug . Ying Hou-Qun, Wang Feng, Chen Xiao-Lin, He Bang-Shun, Pan Yu-Qin, Jie Chen, Liu Xian, Cao Wei-Jun, Peng Hong-Xin, Lin Kang, Wang Shu-K |
Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases. The British journal of surgery 2015 Sep 102 (10): 1175-83. Brudvik K W, Kopetz S E, Li L, Conrad C, Aloia T A, Vauthey J |
Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer. British journal of cancer 2015 Jun 112 (12): 1888-94. Rowland A, Dias M M, Wiese M D, Kichenadasse G, McKinnon R A, Karapetis C S, Sorich M |
Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy. World journal of gastroenterology 2016 Aug 22 (30): 6944-54. Lo Nigro Cristiana, Ricci Vincenzo, Vivenza Daniela, Granetto Cristina, Fabozzi Teresa, Miraglio Emanuela, Merlano Marco |
Effect of RAS status on anti-EGFR monoclonal antibodies + 5-FU infusion-based chemotherapy in first-line treatment of metastatic colorectal cancer: A meta-analysis. Meta gene 2016 Sep 9 110-9. Zhou Mingyi, Yu Ping, Hou Kezuo, Fu Lingyu, Chen Ying, Qu Jinglei, Qu Xiujuan, Liu Yunpeng, Zhang Jingdo |
Efficacy of cetuximab-based chemotherapy in metastatic colorectal cancer according to RAS and BRAF mutation subgroups: A meta-analysis. Molecular and clinical oncology 2016 Jun 4 (6): 1017-1024. Lin L I, Chen Lu-Lu, Wang You, Meng Xiang-Yu, Liang Chen, Zhou Fu-Xia |
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis. The pharmacogenomics journal 2016 Nov . Morgen E K, Lenz H-J, Jonker D J, Tu D, Milano G, Graziano F, Zalcberg J, Karapetis C S, Dobrovic A, O'Callaghan C J, Liu |
Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours. European journal of cancer (Oxford, England : 1990) 2016 Jan 55 122-130. Rowland Andrew, Dias Mafalda M, Wiese Michael D, Kichenadasse Ganessan, McKinnon Ross A, Karapetis Christos S, Sorich Michael |
Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis. Medicine 2017 Sep 96 (35): e7882. Kwak Min Seob, Cha Jae Myung, Yoon Jin Young, Jeon Jung Won, Shin Hyun Phil, Chang Hye Jung, Kim Hyung Kyung, Joo Kwang Ro, Lee Joung |
The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis of patient and study characteristics. Cancer medicine 2019 Aug . Bylsma Lauren C, Dean Rebecca, Lowe Kimberly, Sangaré Laura, Alexander Dominik D, Fryzek Jon |
Clinicopathological Significance of BRAF Mutation in Colorectal Cancer: An Updated Meta-Analysis. Journal of Cancer 2019 7 10 (10): 2332-2341. Wang Jianhua, Shen Jiajia, Huang Chi, Cao Meng, Shen Lizo |
Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis. Cancer medicine 2019 Dec . Bylsma Lauren C, Gillezeau Christina, Garawin Tamer A, Kelsh Michael A, Fryzek Jon P, Sangaré Laura, Lowe Kimberly |
Impact of Use of Gastric-Acid Suppressants and Oral Anti-Cancer Agents on Survival Outcomes: A Systematic Review and Meta-Analysis. Cancers 2020 4 12 (4): . Indini Alice, Petrelli Fausto, Tomasello Gianluca, Rijavec Erika, Facciorusso Antonio, Grossi Francesco, Ghidini Miche |
A Systematic Literature Review and Meta-Analysis Describing the Prevalence of KRAS, NRAS, and BRAF Gene Mutations in Metastatic Colorectal Cancer. Gastroenterology research 2020 11 13 (5): 184-198. Levin-Sparenberg Elizabeth, Bylsma Lauren C, Lowe Kimberly, Sangare Laura, Fryzek Jon P, Alexander Dominik |
Plasma ctDNA RAS status selects patients for anti-EGFR treatment rechallenge in metastatic colorectal cancer: a meta-analysis. Experimental oncology 2021 09 43 (3): 252-256. Vlachou M S, Mauri D, Zarkavelis G, Ntellas P, Tagkas C, Gkoura S, Pentheroudakis |
KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis. Caspian journal of internal medicine 2020 11 (4): 355-369. Yari Abolfazl, Afzali Asiyeh, Aalipour Mostafa, Nakheai Mehran, Zahedi Mohammad Jav |
Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors. Frontiers in oncology 2021 11 752918. Araujo Jhajaira M, Rosas Gina, Belmar-López Carolina, Raez Luis E, Rolfo Christian D, Schwarz Luis J, Infante-Huaytalla Ulises, Paez Kevin J, García Luis R, Alvarado Hober, Ramos Fany P, Delgado-Espinoza Sheyla S, Cardenas-Farfan Jhon B, Cornejo Melanie, Zanabria Daniel, Colonio-Cossio Christian, Rojas-Jefferson Mario, Pinto Joseph |
Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer. Targeted oncology 2022 Jun . Tan Elaine S, Fan Wenyi, Knepper Todd C, Schell Michael J, Sahin Ibrahim H, Fleming Jason B, Xie H |
Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC cancer 2023 11 23 (1): 1117. Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu, Yueqiu G |
- Page last reviewed:Feb 1, 2024
- Content source: